10X Genomics stock plunges to 52-week low of $11.89
In a stark reflection of the challenges facing the biotech sector, 10X Genomics Inc (NASDAQ:TXG) stock has tumbled to a 52-week low, touching down at $11.89. According to InvestingPro data, technical ...
AZoLifeSciences on MSN30m
Study Uncovers Immune Cell Interaction Driving Aggressive Brain Tumor Growth
A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research led by investigators at the Johns Hopkins Kimmel ...